Liver Function
MLTD 2107 Clinical Chemistry II: Liver Function
Overview
Course: MLTD 2107 Clinical Chemistry II
Institution: Nova Scotia Community College
All rights reserved for intellectual property. Unauthorized reproduction or distribution is strictly prohibited.
Anatomy of the Liver
Diagram Descriptions: Anatomy Overview
Diaphragm
Right lobe of liver
Gallbladder
Falciform ligament
Left hepatic vein
Left lobe
Inferior vena cava
Celiac artery
Hepatic artery
Common bile duct
Portal vein (branch)
Blood Flow and Hepatic Structure
Liver Cellular Structure
Bile duct, bile canal
Kupffer cells: specialized macrophages in the liver
Hepatic cells: main functional cells of the liver
Branches of hepatic portal vein: bring nutrient-rich blood from digestive organs
Branch of hepatic artery: brings oxygen-rich blood to the liver
Hepatic sinusoids: capillary-like structures facilitating blood flow
Central canal: outflow for blood from the liver
Liver Function: Excretion and Secretion
Main Excretory Products
Urine
Bile: produced from components such as bile acids/salts, bile pigments (mainly bilirubin), cholesterol, phospholipids, proteins, water, and electrolytes
Production Statistics:
Total bile produced: 3 L/day
Total bile excreted: 1 L/day
Bilirubin: principal pigment derived from the breakdown of red blood cells (RBCs) after approximately 126 days of their lifespan
Iron: returned to stores via transferrin
Globin: reverts to amino acids to synthesize new proteins
Heme: converts to biliverdin, then to bilirubin within 2-3 hours, and is transported to liver bound to albumin.
Bilirubin Metabolism
Forms of Bilirubin
Unconjugated Bilirubin:
Also known as "Indirect" bilirubin
Properties: water-insoluble and toxic
Transported in hepatocytes by Ligandin to the endoplasmic reticulum (ER)
Conjugated Bilirubin:
Subjected to conjugation with glucuronic acid through the enzyme uridyldiphosphate glucuronyl transferase (UDPGT)
Resulting in bilirubin diglucuronide, which is water-soluble, enabling transport to bile canaliculi, hepatic duct, and ultimately the intestines.
Important Notes on Bilirubin Handling
The liver must be functional to process and eliminate 200-300 mg of bilirubin daily.
Bilirubin must undergo conjugation for elimination.
Most bilirubin is excreted in feces as urobilin, with a small amount appearing in urine as urobilinogen (UBG).
A very small concentration remains in plasma, primarily as unconjugated bilirubin.
Liver Functions: Synthesis and Metabolism
Carbohydrate Metabolism
Ingested carbohydrates are directed to the liver for:
Utilizing glucose for energy
Circulating glucose to other tissues
Storage as glycogen via glycogenesis
Mobilization through glycogenolysis
Gluconeogenesis from pyruvate, lactate, and amino acids.
Lipid Metabolism
Synthesized when nutritional status is adequate.
Gathers dietary free fatty acids and those synthesized in the liver
Catabolized to yield acetyl-CoA, which is then transformed into triglycerides, phospholipids, cholesterol (70% of body’s cholesterol), very-low-density lipoprotein (VLDL), bile acids, and ketones.
Metabolizes and removes lipids using lipoproteins.
Protein Synthesis
The liver synthesizes all proteins except for immunoglobulins and adult hemoglobin.
Synthesized proteins include albumin, coagulation factors, transport proteins, and other significant proteins.
Degradation leads to the release of ammonia, entering the urea cycle for processing.
Note: Total protein measurement involves a Biuret reaction, where copper ions react with peptide bonds.
Liver Function: Detoxification and Drug Metabolism
Acts as a “Gatekeeper” regulating substances between the gastrointestinal tract and systemic circulation.
Engages in “first pass” metabolism.
Detoxification occurs through two mechanisms:
Reversible Binding: Inactivates materials on a temporary basis.
Chemical Modification: Involves converting harmful substances into less toxic forms, for instance:
Ammonia getting converted via urea cycle
Drugs transforming into metabolites before excretion. For instance:
Alcohol metabolizes to acetaldehyde, then acetic acid.
Liver Function: Storage
Important For Storing:
Glycogen: Rapidly mobilized energy source.
Bilirubin: Intermediate product of heme metabolism.
Amino Acids: Essential for protein synthesis.
Lipids: Include phospholipids and other essential fats.
Vitamins: A, B12, D, E, K essential to body function.
Minerals: Iron (within ferritin) and copper are stored in the liver.
Important Biochemical Pathways in the Liver
Catabolic Pathways
Transamination: converting amino acids to ketones and acetyl-CoA.
Fatty acid oxidation: breaking down fats to produce ketones.
Urea cycle: detoxifying ammonia by converting it to urea.
Bilirubin metabolism: processing heme from hemoglobin breakdown.
Drug metabolism: processing xenobiotic compounds.
Anabolic Pathways
Albumin Synthesis: Essential for maintaining oncotic pressure in blood.
Clotting Factor Synthesis: Vital for blood coagulation processes.
Lipoprotein Synthesis: Includes synthesis of VLDL and other forms.
Gluconeogenesis: Synthesizing glucose from non-carbohydrate sources.
Bile Acid Synthesis: Producing bile acids for digestion.
Liver Diseases: Jaundice
Definition: Yellowing of skin, sclera of eyes, and mucous membranes.
Classification of Jaundice:
Prehepatic Jaundice:
Often related to hemolytic anemia, where increased bilirubin is presented to the liver.
Lab findings show increased unconjugated bilirubin in serum which is not found in urine due to its insolubility.
Hepatic Jaundice:
Arises from liver defects; can increase either unconjugated or conjugated bilirubin depending on the pathology. Liver function tests typically show elevated liver enzymes and possible protein synthesis decreases.
Posthepatic Jaundice:
Occurs due to obstruction of bile flow; conjugated bilirubin rises in serum and is excreted in urine; results in pale stools.
Detailed Types of Hepatic Jaundice
Unconjugated Hyperbilirubinemia:
Gilbert’s Syndrome: Benign hereditary condition leading to intermittent elevated unconjugated bilirubin without signs of hemolysis.
Crigler-Najjar Syndrome: Rare condition causing severe unconjugated hyperbilirubinemia due to hereditary conjugation defects.
Conjugated Hyperbilirubinemia:
Dubin-Johnson Syndrome: Defect in excreting conjugated bilirubin, characterized by dark granules in the liver tissue.
Rotor Syndrome: Similar to Dubin-Johnson but without granule formation.
Liver Diseases: Cirrhosis
Pathophysiology: Liver damage leading to scar tissue formation, obstructed blood flow, and liver dysfunction.
Symptoms: Fatigue, jaundice, nausea, weight loss, ascites, and intense itching.
Common Causes: Chronic alcohol use, Hepatitis C, chronic Hepatitis B or D, autoimmune hepatitis, and inherited disorders.
Liver Tumors
Types:
Primary Tumors: Rare forms originating in the liver.
Metastatic Tumors: Majority are secondary cancers, with colon, lung, and breast as primary sources.
Benign Tumors: Examples include hepatocellular adenoma and hemangiomas.
Malignant Tumors: Most notably, hepatocellular carcinoma (HCC) is common, particularly following cirrhosis or chronic viral hepatitis infection.
Drug and Alcohol-Related Liver Disorders
Responsible for 1/3 to 1/2 of acute liver failure cases, primarily due to immune-mediated injury to hepatocytes.
Ethanol: Most frequently implicated drug in liver toxicity, where 90% of ingested alcohol is processed through specific metabolic pathways in the liver.
Three Stages of Liver Injury from Alcohol:
Alcoholic Fatty Liver: Initial stage with mild inflammation.
Alcoholic Hepatitis: Accompanied by more significant symptoms and enzyme elevations.
Alcoholic Cirrhosis: Advanced stage, severely affecting liver function and overall health prognosis.
Hepatitis Overview
Definition: Liver inflammation due to various causes including viral (A, B, C, D, E), bacteria, drugs, toxins, and autoimmune processes.
Symptoms: Jaundice, fatigue, abdominal discomfort, elevated liver enzymes.
Diagnostic Lab Findings: Marked elevations of transaminases (AST, ALT) and bilirubin levels.
Hepatitis A
Epidemiology: Highly prevalent worldwide through fecal-oral transmission, mainly from contaminated food and water.
Clinical Markers: Presence of IgM anti-HAV indicates active infection; recovery typically occurs within 3 weeks without chronicity.
Hepatitis B
Epidemiology: Approximately 2 billion infected globally, with 350-400 million chronic carriers.
Transmission: Blood, sexual contact, and perinatal exposure.
Clinical Progression: Most cases are asymptomatic; some may develop fulminant infections with high mortality risk.
Laboratory Monitoring: Serologic markers indicate current infection, past infection, and immunological responses.
Hepatitis C
Transmission: Primarily through transfused blood products; increasing incidence through drug use and sexual contact.
Chronic Infection: About 80% develop chronic infections, significantly increasing the risk of cirrhosis and hepatocellular carcinoma over time.
Diagnostic Testing: Anti-HCV antibodies and PCR for serum HCV RNA are critical for both diagnosis and monitoring treatment.
Hepatitis D
Can only replicate in the presence of Hepatitis B virus (HBV).
Common in carriers of HBV; increases risks for severe liver disease.
Hepatitis E
Fecal-oral transmission similar to Hepatitis A, often through contaminated water sources, especially in developing nations.
More severe in pregnant women with potentially high fatality rates.
Liver Function Tests: Bilirubin Testing
Bilirubin Measurement Techniques:
Diazo Reaction: Involves serum reactions to determine total (conjugated + unconjugated) bilirubin concentrations.
Conjugated bilirubin is water-soluble, reacting with diazotized sulfanilic acid; unconjugated bilirubin requires accelerator for adequate measurement.
Reference Intervals for Bilirubin:
Normal ranges:
Total bilirubin: 3-17 µmol/L
Conjugated: 0-3 µmol/L
Unconjugated: 3-14 µmol/L
Circulating concentrations exceeding 300 µmol/L indicate severe pathology.
Testing Considerations for Bilirubin
Collection: Serum should be protected from light exposure to prevent degradation of bilirubin levels.
Common Sources of Errors: Hemolysis can lead to false decreases; significant lipemia may cause false increases.
Enzyme Testing for Liver Function
Aminotransferases
Elevations in AST and ALT are indicative of hepatocellular damage; differentiation between liver and other organ dysfunctions is essential.
Phosphatases
Alkaline phosphatase (ALP): Elevated levels indicate biliary obstruction; differentiate from other sources via 5’-nucleotidase testing.
GGT: Used for determining hepatobiliary disease versus bone disorders.
Testing for Hepatic Synthesis: Includes serum protein levels (especially albumin) and prothrombin time (PT) measurements to assess functional integrity of the liver.
Conclusion and References
This study guide collates critical insights regarding liver function, its diseases, and concept assessments pertinent to clinical chemistry and diagnostics.
Key References:
Clinical Chemistry: Principles, Techniques, and Correlations. 8th Edition, Wolters Kluwer 2018
Tietz: Fundamentals of Clinical Chemistry, 6th Edition, Elsevier, 2008.